Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Exercise of Options

Faron Pharmaceuticals Oy (“Faron” or the “Company”) Exercise of options Issue of equity Company announcement, 25 March 2020 at 9.45 AM (EET)   TURKU, FINLAND – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, announces that it has received a notification from Toni Hänninen, Faron’s CFO, to exercise D options over 40,000 ordinary shares in the Company at an exercise price of EUR 1.09 (approx. GBP 0.94) per share under the Company’s 2015 Option Plan (“New Ordinary Shares”). The terms and conditions of the 2015 Option

IRLAB’s drug candidate mesdopetam's mechanism of action receives confirmation by independent scientists

IRLAB (Nasdaq Stockholm: IRLAB A) announced today that independent scientists have confirmed that the dopamine D3 receptor (D3R) is a highly promising drug target with therapeutic potential in levodopa-induced dyskinesia, especially when the receptor’s unique signaling properties are taken into account. IRLAB’s mesdopetam is currently the most advanced D3R antagonist compound in the global neurology pipeline. It is used in the scientific article to exemplify a compound that could have an impact on the management of anumber of disorders marked by aberrant D3R activity. The article was

Follicum appoints new CEO and establishes new role as Chief Scientific Officer

Follicum AB announces today that the company has recruited Dr. Kim Arvid Nielsen as new CEO, taking office on April 6, 2021. He has extensive experience in business development, investor relations and drug development from leading positions in both small and large pharmaceutical companies. At the same time, Follicum is establishing a new position as Chief Scientific Officer. The changes are implemented to strengthen the company's organization to keep in step with the progress made in its pharmaceutical projects.Follicum has recently made continued progress in its pharmaceutical projects

Germany cancels hard lock-down during Easter but extended lock-down continues as announced before

Kamux Corporation    Press Release    25 March 2021 at 9:40 (EET) Germany cancels hard lock-down during Easter but extended lock-down continues as announced before Germany cancels hard lock-down during Easter which means that retail stores can be open depending on the regional incidence of infections and measures related to that. Kamux’s stores in Germany will be open according to local guidelines and restrictions. The stores can be open if the incidence of infections is low, with higher incidence of infections available will be pre-booked store appointments, click&collect option or

French hospital specialized in neuroscience chooses Sectra’s digital pathology solution to improve diagnostics

Linköping, Sweden and Paris, France – March 25, 2021 – GHU Paris psychiatrie & neurosciences has ordered a digital pathology solution from international medical imaging IT and cybersecurity company Sectra  (STO: SECT B). The digital technology will maximize workflow efficiency and improve collaboration between pathologists, pushing the limits even further within the field of neuropathology. This will ultimately lead to more accurate and faster diagnoses for patients, which is key when deciding on a suitable treatment, especially in precision medicine.“As an expert

PPG Industries, Inc. has received approval from the Ministry of Economic Affairs and Employment of Finland for the acquisition of all Tikkurila Oyj’s shares

TIKKURILA OYJTender Offer March 25, 2021 at 9.35 a.m. EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. PPG Industries, Inc. (“PPG” or the “Offeror”), a corporation incorporated under the laws of Pennsylvania, and Tikkurila Oyj (“Tikkurila” or the “Company”) have on December 18, 2020 entered into a combination agreement (the “Combination Agreement”), which was amended

Redsense signs new distributor agreement with Regional Health Care Group in Australia

Redsense Medical AB announces that the Company has signed a new exclusive distributor agreement with Regional Health Care Group (RHCG) in Australia, covering the distribution of the Redsense Alarm system to the markets of Australia and New Zealand. In addition, RHCG has shown considerable interest in a further development of the collaboration to include the Redsense Clamp accessory when it becomes available. The Redsense Clamp is currently under development, and Redsense will seek opportunities to conduct an evaluation of the system in Australia. “We are very happy to announce this

Nel ASA: Signs MoU with Haldor Topsoe for delivery of end-to-end green ammonia and methanol solutions

(Oslo, 25 March 2021) Nel ASA (Nel, OSE:NEL) has entered into an MoU with Haldor Topsoe with the intent to offer customers end-to-end green ammonia and methanol solutions, based on globally leading technologies from the two companies. "We are very excited to join forces with Haldor Topsoe for possible future development of end-to-end green ammonia and green methanol solutions to customers, both which are widely regarded as important carbon free fuels and energy carriers for the future. This is a market that is expected to grow significantly in the years to come and we look forward to

Last patient with liver cancer included in the monotherapy part of Medivir's phase Ib study with MIV-818

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that the last patient with advanced liver cancer has been included in the first part of the phase Ib study with MIV-818. Like the other patients in the study, the patient is dosed in cycles of three weeks starting with MIV-818 as monotherapy for five days. In parallel, the company is preparing part two of the phase Ib study to be able to begin during the second half of 2021. · It is gratifying that we this far have managed to carry out the study without any major delays despite the ongoing Covid-19 pandemic. We are

Nightingale Health Plc – Managers’ transactions – Timo Soininen

Nightingale Health Plc – Managers’ transactions – 25 March 2021 9:30 a.m. (Finnish time)Nightingale Health Plc – Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Soininen, Timo Position: Member of the Board/Deputy member Issuer: Nightingale Health Oyj LEI: 743700WUIPC24LVMLO66 Notification type: INITIAL NOTIFICATION Reference number: 743700WUIPC24LVMLO66_20210324144018_2 ____________________________________________ Transaction date: 2021-03-24 Venue: FIRST NORTH FINLAND (FNFI)

Notice of Faron Pharmaceuticals Ltd’s AGM

NOTICE OF Faron pharmaceuticals LTD’s Annual GENERAL MEETING Shareholders of Faron Pharmaceuticals Ltd (the “Company”) are notified of the Annual General Meeting (the “AGM”) to be held on 23 April 2021 at 2:00 p.m. EEST (Finnish time) at the premises of Inderes Oy at Itämerentori 2, FI-00180 Helsinki, Finland. The shareholders of the Company may participate in the AGM and exercise their shareholder rights only by voting in advance, by submitting counterproposals in advance and asking questions in advance in accordance with the instructions given in this notice and otherwise by the

Endomines reports that Pampalo mine deepening and decline development starts in April 2021

Endomines AB, Stock Exchange Release 25 March 2021 at 08:30 CET The first steps in taking Pampalo mine back into production has progressed well. The mine site preparation for production commenced in February, when the Mill and Crushing plant were tested. The long lead-time items needed for production have been identified and those orders will be placed in April this year.  The Tailing dam’s capacity will be increased, and design work and contract document preparation will also commence in April. After two years under care and maintenance, the existing decline will undergo a

Tele2’s Annual and Sustainability Report 2020

Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) today published its Annual and Sustainability Report 2020, which is available at www.tele2.com.Highlights from the Annual Report 2020: · Progressed the more-for-more strategy in Sweden and achieved a good uptake of mobile postpaid subscriptions and a continued conversion from prepaid. · Continued momentum and growth in the Baltics, executing on the mobile-centric convergence strategy, including launching video services. · First operator to launch real 5G in a public network in Sweden and first operator with 5G

Exclusive partnership agreement with GC Healthcare

Company Announcement No. 24-2021 Copenhagen, March 25, 2021 Shape Robotics are pleased to announce the signing of an exclusive partner agreement with the danish company GC Healthcare that is a leading supplier of Purification Stations. The agreement is valid from today. The reseller agreement gives Shape Robotics the rights to sell GC Healthcares Purification Stations globally with partial exclusivity in the following selected markets Great Britain, Germany, USA, Singapore, Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and United Arab Emirates for a period of minimum 12 months. The

Harvard Researchers Purchase HoloMonitor

Partners HealthCare International  in Boston, Massachusetts, recently ordered its first and fully equipped HoloMonitor unit.Partners HealthCare operates five Harvard Medical School-affiliated teaching hospitals. Unlike many medical schools, Harvard does not own or operate any hospitals. Instead, several hospitals are affiliated with Harvard to provide clinical training and research. With its teaching hospitals, Harvard Medical School  is consistently ranked as the top medical school in the world. Massachusetts General

Faron´s Annual Report 2020 published

Faron Pharmaceuticals Oy (“Faron” or the “Company”) Faron´s Annual Report 2020 published Company announcement, 25 March 2021 at 9.15 AM (EET)  TURKU – FINLAND – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, announces that its Annual Report for the year 2020 has been published today. Faron Pharmaceuticals´ Annual Report 2020 and audited financial statements for the accounting period 1 January - 31 December 2020 have been published in English and its financial statements in Finnish, on the Company's website https://www.

Perwyn-backed Miss Group acquires Finnish web hosting firm Seravo

This is the third Finnish acquisition for the ambitious, fast-growth web hosting company.International web hosting business, Miss Group , has acquired Finnish-based Seravo Oy  as part of its global buy and build strategy. Established in 2011, Seravo - the world’s fastest WordPress server provider - offers premium hosting services and upkeep for over 4,000 WordPress sites. Seravo has reported steady double-digit revenue growth over recent years, with revenues in the financial year to December 2020 of €1.5m forecast to increase to €1.9m in

Minesto publishes the annual report for 2020

Minesto's annual report for the financial year 2020 is now available, in Swedish only, on the company's website.To download the annual report, go to: www.minesto.com/investor/rapporter. The annual report is published only in Swedish. For additional information please contact Martin Edlund, CEO+46 31 29 00 60press@minesto.com About Minesto Minesto is a leading marine energy technology company with the mission to minimise the global carbon footprint of the energy industry by enabling commercial power production from the ocean. Minesto’s award winning and patented product,

AZD1222 US Phase III primary analysis confirms safety and efficacy

25 March 2021 07:00 GMT AZD1222 US Phase III primary analysis confirms safety and efficacy 76% vaccine efficacy against symptomatic COVID-19 100% efficacy against severe or critical disease and hospitalisation 85% efficacy against symptomatic COVID-19 in participants aged 65 years and over   Positive high-level results from the primary analysis of the Phase III trial of AZD1222 in the US have confirmed vaccine efficacy consistent with the pre-specified interim analysis announced on Monday 22 March 2021.   These results have been presented to the independent Data

Aker Solutions Partners Up for Sustainable Energy Projects in the UK

March 25, 2021 - Aker Solutions and Doosan Babcock have agreed to jointly deliver projects for low-carbon solutions and renewable energy in the UK. The partners will particularly focus on pursuing and winning contracts for new hydrogen production plants, and facilities for carbon capture, utilization and storage (CCUS). Opportunities for other projects within the process and energy industries will also be explored.The duo has signed a memorandum of understanding (MoU) and established a team with key people from both organizations. The combination of Aker Solutions and Doosan Babcock

Apetit updates its corporate responsibility programme – the target is to reduce emissions by 75 per cent by 2025

Apetit Plc, press release 25 March 2021 at 9:00 a.m.Apetit Group is updating its corporate responsibility programme and making commitments including a 75 per cent reduction in emissions* from its own operations and transitioning to 100 per cent recyclable packaging materials**. In its products, Apetit relies on domestic raw-materials, vegetables and local fish. The corporate responsibility programme is based on sustainable food choices: Through its operations, Apetit wants to contribute to a food supply chain that supports the well-being of people and the environment. “As a food

Notice of Annual General Meeting 2021

The Annual General Meeting of Aker BP ASA will be held on Thursday 15 April 2021 at 09:00 (CEST) at Akerkvartalet, Oksenøyveien 10 (building B), Lysaker, Norway.   The notice and the proposal from the company's nomination committee are attached. Due to the outbreak of the corona virus Covid-19 shareholders are encouraged to abstain from appearing in person at the general meeting, but rather participate by means of advance votes or by granting a proxy. Shareholders not enrolled by the set registration deadline, may be denied attendance. Shareholders should note that additional

Concentric AB partners with hybrid and electric systems provider MAGTEC to develop a new electric oil pump for refuse truck applications

Concentric AB has extended its customer base with a supplier nomination from MAGTEC, a UK supplier of hybrid and electric drive systems used in zero emission refuse vehicles. A new electric oil pump has been developed for main traction motor cooling. Production will start during 2021 and sales revenue from this new contract are estimated to be MSEK 50 over the next five years. The electric oil pump has the following key benefits: · Robust design which includes a wet rotor eliminating the possibility of a dynamic seal failure, · Long service life aided by liquid cooled electronics

There are no items matching the current filter
There are no more items matching the current filter
Back to top